Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 137571000087117 | RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 96411000087114 | RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 96421000087118 | HB RECOMBIVAX HB dialysis MC | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 97531000087117 | HB RECOMBIVAX HB pour dialyse MC | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | Adult and dialysis vaccine product containing only Hepatitis B virus high strength antigen (medicinal product) | true | Inferred relationship | Some | ||
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has product characteristic | Haemodialysis population | false | Inferred relationship | Some | ||
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has supplier | Merck Canada Inc. (supplier) | true | Inferred relationship | Some | ||
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has product characteristic | Adulthood (qualifier value) | false | Inferred relationship | Some | ||
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Hepatitis B virus recombinant surface antigen | true | Inferred relationship | Some | 1 | |
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has ingredient characteristic (attribute) | dose élevée | false | Inferred relationship | Some | 1 | |
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Hepatitis B virus vaccine (substance) | false | Inferred relationship | Some | 1 | |
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has ingredient qualitative strength | dose élevée | true | Inferred relationship | Some | 1 | |
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has target population | Adult population (qualifier value) | true | Inferred relationship | Some | ||
| RECOMBIVAX HB 40 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has target population | Haemodialysis population | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR